Measurement of serum CHE activity [4], serum alanine transaminase (ALT) levels and serum aspartate aminotransferase (AST) levels [5] is important for diagnosis of liver diseases, and ALT is a sensitive biochemical marker used to evaluate damage to hepatic parenchymal cells [5]. This evidence concerns the gene GPT and liver disorder.